• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受氨苯砜长效制剂治疗的麻风患者的血液氨苯砜水平。

Blood dapsone levels in leprosy patients treated with acedapsone.

作者信息

George J, Balakrishnan S

出版信息

Indian J Lepr. 1986 Jul-Sep;58(3):401-6.

PMID:3794408
Abstract

The metabolism of the repository drug acedapsone (DADDS,4,4'-diacetyldiaminodiphenyl sulfone) was studied in 15 individuals receiving 225 mg of DADDS, intramuscularly for a period of 75 days. Plasma levels of DDS were determined on the 2nd, 7th, 15th, 30th, 60th and 75th day after administration of the drug by spectrophoto-fluorometric technique. The mean peak levels of DDS (85.36 ng/ml) were noticed on 7th day followed by a gradual decrease in DDS concentration. The mean half-life level (44.53 ng/ml) of DDS were observed around the 15th day. The mean DDS level for the entire period of observation after one dose was 41.95 ng/ml. On the 75th day, the DDS level reached the minimum value of 14.76 ng/ml which was still about 5 times more than the minimal inhibitory concentration (MIC) level of DDS against M. leprae (3 ng/ml). The results are discussed.

摘要

在15名接受225毫克醋氨苯砜(DADDS,4,4'-二乙酰二氨基二苯砜)肌肉注射,为期75天的个体中,对储存药物醋氨苯砜的代谢情况进行了研究。在给药后的第2天、第7天、第15天、第30天、第60天和第75天,采用分光光度荧光法测定血浆中氨苯砜(DDS)的水平。DDS的平均峰值水平(85.36纳克/毫升)在第7天被注意到,随后DDS浓度逐渐下降。在第15天左右观察到DDS的平均半衰期水平(44.53纳克/毫升)。一剂药物后整个观察期的DDS平均水平为41.95纳克/毫升。在第75天,DDS水平达到最小值14.76纳克/毫升,这仍比DDS对麻风杆菌的最低抑菌浓度(MIC)水平(3纳克/毫升)高约5倍。对结果进行了讨论。

相似文献

1
Blood dapsone levels in leprosy patients treated with acedapsone.接受氨苯砜长效制剂治疗的麻风患者的血液氨苯砜水平。
Indian J Lepr. 1986 Jul-Sep;58(3):401-6.
2
Acedapsone treatment of leprosy patients: response versus drug disposition.氨苯砜治疗麻风病患者:疗效与药物处置
Am J Trop Med Hyg. 1977 Jan;26(1):127-36. doi: 10.4269/ajtmh.1977.26.127.
3
Activity and effective serum level of repository sulphones (DADDS) in lepromatous leprosy.瘤型麻风中长效砜类药物(二乙酰氨苯砜)的活性及有效血清水平
Lepr India. 1979 Jul;51(3):358-62.
4
Susceptibility of Mycobacterium leprae to dapsone as a determinant of patient response to acedapsone.麻风分枝杆菌对氨苯砜的敏感性作为患者对醋氨苯砜反应的决定因素。
Antimicrob Agents Chemother. 1976 Jan;9(1):102-12. doi: 10.1128/AAC.9.1.102.
5
Armadillo as a model for studying chemotherapy of leprosy: preliminary studies.
Indian J Lepr. 1986 Jan-Mar;58(1):19-28.
6
Chemical drug delivery systems: I. Preparation and evaluation of prodrugs of dapsone.化学药物递送系统:I. 氨苯砜前药的制备与评价
Indian J Lepr. 1985 Oct-Dec;57(4):756-62.
7
Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years.在巴布亚新几内亚卡里穆伊地区对麻风病人使用醋氨苯砜双乙酰氨苯砜(DADDS)进行治疗:六年时的情况。
Am J Trop Med Hyg. 1975 May;24(3):485-95. doi: 10.4269/ajtmh.1975.24.485.
8
Metabolism and interactions of antileprosy drugs.抗麻风病药物的代谢与相互作用。
Biochem Pharmacol. 2020 Jul;177:113993. doi: 10.1016/j.bcp.2020.113993. Epub 2020 Apr 24.
9
Clinical trial of DADDS in lepromatous leprosy.二烯丙基二硫代氨基甲酸钠(DADDS)治疗瘤型麻风的临床试验。
Lepr India. 1976 Jul;48(3):238-43.
10
The pharmacokinetics of dapsone and acetylated dapsone in serum and saliva.氨苯砜及乙酰化氨苯砜在血清和唾液中的药代动力学。
Int J Clin Pharmacol Biopharm. 1979 Apr;17(4):159-63.

引用本文的文献

1
Antitubercular effect of 8-[(4-Chloro phenyl) sulfonyl]-7-Hydroxy-4-Methyl-2H-chromen-2-One in guinea pigs.8-[(4-氯苯基)磺酰基]-7-羟基-4-甲基-2H-色烯-2-酮对豚鼠的抗结核作用
J Pharmacol Pharmacother. 2011 Oct;2(4):253-60. doi: 10.4103/0976-500X.85951.
2
Clinical pharmacokinetic considerations in the treatment of patients with leprosy.麻风病患者治疗中的临床药代动力学考量
Clin Pharmacokinet. 1989 Jun;16(6):365-86. doi: 10.2165/00003088-198916060-00003.